ADAR1 Capital Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.99M Hold
5,122,105
1.53% 13
2025
Q1
$11.2M Buy
5,122,105
+19,100
+0.4% +$41.8K 2.08% 11
2024
Q4
$16.6M Buy
+5,103,005
New +$16.6M 3.31% 8